CliffBio
small molecule

PROPANTHELINE BROMIDE

PROPANTHELINE BROMIDE

Loss of exclusivity—loss of exclusivity
CompanyPar →See this company's full patent-cliff portfolio

Drug detail

Brand namePROPANTHELINE BROMIDE
Active ingredientPROPANTHELINE BROMIDE
Strength15MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalDecember 1983
Marketing statusDISCN

More from Par

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PROPANTHELINE BROMIDE patent cliff — loss of exclusivity — | CliffBio